HomePPCB • OTCMKTS
add
Propanc Biopharma Inc
Previous close
$2.91
Year range
$1.25 - $222.00
Market cap
56.24K USD
Avg Volume
880.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 213.38K | -51.29% |
Net income | -430.18K | 26.39% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -213.31K | 51.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.63K | -79.58% |
Total assets | 78.53K | -67.54% |
Total liabilities | 4.24M | 11.35% |
Total equity | -4.16M | — |
Shares outstanding | 15.37K | — |
Price to book | -0.01 | — |
Return on assets | -750.42% | — |
Return on capital | 17.92% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -430.18K | 26.39% |
Cash from operations | -6.27K | 97.37% |
Cash from investing | — | — |
Cash from financing | 79.82K | -70.86% |
Net change in cash | 5.36K | -91.75% |
Free cash flow | -157.95K | -511.36% |
About
Founded
2007
Website
Employees
2
